Shuttle Pharmaceuticals Files 8-K/A on Completed Asset Transaction

What Happened Shuttle Pharmaceuticals Holdings, Inc. (SHPH) filed a Form 8-K/A on August 17, 2026 to amend a previously filed Form 8-K. The amendment relates to Item 2.01 (Completion of Acquisition or Disposition of Assets) and is intended to include the financial statements and exhibits required under Item 9.01 that were not included in the original filing.

Key Details

• Filing: Form 8-K/A filed August 17, 2026 (amendment to an earlier 8-K).
• Subject: Item 2.01 — completion of an asset acquisition or disposition previously reported.
• Purpose: The amendment solely adds the financial statements and exhibits required by Item 9.01 to the original report.
• No new transaction terms or dates were announced in this amendment; it supplements the prior disclosure.

Why It Matters This amendment provides the additional financial documentation and exhibits investors need to assess the accounting and financial impact of the completed asset transaction. It is primarily an administrative filing to bring the company’s disclosure into compliance with SEC rules; investors should review the newly filed financial statements and exhibits to understand any changes to assets, liabilities, or pro forma results tied to the transaction.